comparemela.com
Home
Live Updates
Johnson Johnsonjnjannounced - Breaking News
Pages:
Latest Breaking News On - Johnson johnsonjnjannounced - Page 1 : comparemela.com
Johnson & Johnson's Drug Seltorexant Aces Late-Stage Depression Trial - Johnson & Johnson (NYSE:JNJ)
Johnson & Johnson reported successful Phase 3 trial results for seltorexant, an investigational treatment for major depressive disorder with insomnia.
United-states
American
Johnson-johnsonjnjannounced
American-society-of-clinical-psychopharmacology
Johnson
American-society
Clinical-psychopharmacology
Numab-therapeutics
vimarsana © 2020. All Rights Reserved.